clasto-lactacystin beta-lactone has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 20 studies
| Studies (clasto-lactacystin beta-lactone) | Trials (clasto-lactacystin beta-lactone) | Recent Studies (post-2010) (clasto-lactacystin beta-lactone) | Studies (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Trials (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) |
|---|---|---|---|---|---|
| 85 | 0 | 15 | 2,473 | 3 | 1,057 |
| Protein | Taxonomy | clasto-lactacystin beta-lactone (IC50) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50) |
|---|---|---|---|
| Proteasome subunit beta type-11 | Homo sapiens (human) | 1.9893 | |
| Calpain-9 | Homo sapiens (human) | 9.88 | |
| Proteasome subunit alpha type-7 | Homo sapiens (human) | 1.9893 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.9 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.8999 | |
| Aromatase | Homo sapiens (human) | 0.044 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 1.0853 | |
| Proteasome subunit alpha type-1 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-2 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-3 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-4 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-8 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-9 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-5 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-4 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-6 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 0.6088 | |
| Proteasome subunit beta type-10 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-3 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-2 | Homo sapiens (human) | 2.0443 | |
| Proteasome subunit alpha type-6 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha-type 8 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-7 | Homo sapiens (human) | 1.9893 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 16 (80.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dasso, M; Everett, RD; Freemont, P; Kathoria, M; Orr, A; Parkinson, J; Saitoh, H | 1 |
| Becker, J; Jeblick, W; Kauss, H; Kempf, R | 1 |
| McBride, AA; Penrose, KJ | 1 |
| Mizel, SB; Moors, MA | 1 |
| Holmberg, CI; Illman, SA; Kallio, M; Mikhailov, A; Sistonen, L | 1 |
| Nowell, TR; Shang, F; Taylor, A | 1 |
| Calzoni, GL; Crinelli, R; Magnani, M; Scoccianti, V; Speranza, A | 1 |
| Alves dos Santos, CM; Bu, G; Klumperman, J; Sachse, M; Strous, GJ; van Kerkhof, P | 1 |
| Burrows, J; Hale, PD; Hidvegi, T; Perlmutter, DH; Schmidt, B; Teckman, JH | 1 |
| Belbeoc'h, S; Bon, S; Massoulié, J | 1 |
| de Bree, P; Govers, R; Rabelink, TJ | 1 |
| Ancuta, P; Gabuzda, D; McPike, M; Mehle, A; Strack, B; Zhang, C | 1 |
| Itoh, K; Kobayashi, A; Kumagai, T; Kusano, Y; Osada, S; Uchida, K; Usami, H; Yamamoto, M | 1 |
| Chik, CL; Ho, AK; Price, DM; Terriff, DL | 1 |
| Dosenko, VE; Moibenko, AA; Nagibin, VS; Tumanovskaya, LV; Vaage, J; Zagoriy, VY | 1 |
| Bahat, A; Granot, Z; Melamed-Book, N; Orly, J | 1 |
| Li, Z; Matsubara, K; Murayama, T; Sadanari, H; Tanaka, J; Yamada, R | 1 |
| Anwar, A; Fujita, M; Norris, DA | 1 |
| Cai, J; Lin, B; Qu, J; Snider, BJ; Sun, L; Wu, M; Wu, S | 1 |
| Dahlmann, B; Dyck, Y; Eisenhardt, D; Felsenberg, J; Kloetzel, PM; Kloß, A | 1 |
2 review(s) available for clasto-lactacystin beta-lactone and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Opposite effects of proteasome inhibitors in the adrenergic induction of arylalkylamine N-acetyltransferase in rat pinealocytes.
Topics: Adrenergic Agents; Animals; Arylalkylamine N-Acetyltransferase; Lactones; Leupeptins; Models, Biological; Pineal Gland; Protease Inhibitors; Proteasome Inhibitors; Rats; Time Factors | 2006 |
Turnover of StAR protein: roles for the proteasome and mitochondrial proteases.
Topics: Animals; Humans; Lactones; Leupeptins; Mitochondria; Mitochondrial Membranes; Oligopeptides; Peptide Hydrolases; Phosphoproteins; Protease Inhibitors; Proteasome Endopeptidase Complex | 2007 |
18 other study(ies) available for clasto-lactacystin beta-lactone and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.
Topics: Animals; Cell Line; Cricetinae; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Endopeptidases; Herpesvirus 1, Human; Humans; Immediate-Early Proteins; Isomerism; Lactones; Leupeptins; Multienzyme Complexes; Neoplasm Proteins; Nuclear Proteins; Promyelocytic Leukemia Protein; Proteasome Endopeptidase Complex; SUMO-1 Protein; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Ubiquitin-Protein Ligases; Ubiquitin-Specific Peptidase 7; Ubiquitins | 1998 |
Induction of competence for elicitation of defense responses in cucumber hypocotyls requires proteasome activity.
Topics: Adenosine Triphosphatases; Chitinases; Cucumis sativus; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Darkness; Growth Inhibitors; Hydrogen Peroxide; Hypocotyl; Lactones; Leupeptins; Light; Multienzyme Complexes; Proteasome Endopeptidase Complex; RNA, Messenger | 2000 |
Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number.
Topics: Alanine; Animals; Bovine papillomavirus 1; Cattle; Cell Line; Chlorocebus aethiops; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; DNA, Viral; Gene Dosage; Genome, Viral; Lactones; Leupeptins; Multienzyme Complexes; Mutagenesis, Site-Directed; Papilloma; Papillomavirus Infections; Phosphorylation; Proteasome Endopeptidase Complex; Serine; Viral Proteins; Warts | 2000 |
Proteasome-mediated regulation of interleukin-1beta turnover and export in human monocytes.
Topics: Acrylates; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Half-Life; Humans; Interleukin-1; Lactones; Leucine; Leukemia, Monocytic, Acute; Leupeptins; Lipopolysaccharides; Monocytes; Multienzyme Complexes; Neoplasm Proteins; Proteasome Endopeptidase Complex; Tumor Cells, Cultured | 2000 |
Formation of nuclear HSF1 granules varies depending on stress stimuli.
Topics: Blotting, Western; Cell Nucleus Structures; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Heat Shock Transcription Factors; Heat-Shock Proteins; Heat-Shock Response; HeLa Cells; HSP70 Heat-Shock Proteins; Humans; K562 Cells; Lactones; Leupeptins; Microscopy, Fluorescence; Multienzyme Complexes; Phosphorylation; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Recombinant Proteins; Transcription Factors | 2000 |
Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway.
Topics: Animals; Crystallins; Cysteine Proteinase Inhibitors; Lactones; Lens, Crystalline; Leupeptins; Membrane Proteins; Molecular Weight; Oxidative Stress; Peptide Hydrolases; Rabbits; Ubiquitins; Up-Regulation | 2001 |
Inhibition of proteasome activity strongly affects kiwifruit pollen germination. Involvement of the ubiquitin/proteasome pathway as a major regulator.
Topics: Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Fruit; Germination; Lactones; Leupeptins; Magnoliopsida; Multienzyme Complexes; Pollen; Proteasome Endopeptidase Complex; Ubiquitins | 2001 |
Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
Topics: Animals; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Endocytosis; Humans; Lactones; Leupeptins; Ligands; Lysosomes; Multienzyme Complexes; Nerve Growth Factor; Proteasome Endopeptidase Complex; Protein Transport; Receptor, trkA; Receptors, Somatotropin; Transferrin | 2001 |
The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Topics: Acetylcysteine; alpha 1-Antitrypsin; Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Cysteine Endopeptidases; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Fibroblasts; HeLa Cells; Hepatocytes; Humans; Lactones; Leupeptins; Liver; Mice; Multienzyme Complexes; Mutation; Oligopeptides; Precipitin Tests; Proteasome Endopeptidase Complex; Protein Binding; Rats; Time Factors; Transfection; Tumor Cells, Cultured | 2001 |
The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway.
Topics: Acetylcholinesterase; Alkaline Phosphatase; Amino Acid Sequence; Amino Acid Substitution; Amino Acids, Aromatic; Animals; Chlorocebus aethiops; Conserved Sequence; COS Cells; Cysteine; Dimerization; Endoplasmic Reticulum; Humans; Lactones; Leupeptins; Molecular Sequence Data; Nippostrongylus; Peptides; Protein Subunits; Rats; Serine | 2003 |
Involvement of the proteasome in activation of endothelial nitric oxide synthase.
Topics: Animals; Aorta; Blotting, Western; Capillaries; Cattle; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluoresceins; Lactones; Leupeptins; Mice; Multienzyme Complexes; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Proteasome Endopeptidase Complex | 2003 |
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Topics: APOBEC-3G Deaminase; Cell Line; Cell Line, Tumor; Conserved Sequence; Cysteine; Cysteine Endopeptidases; Cytidine Deaminase; Drug Interactions; Enzyme Inhibitors; Gene Deletion; Gene Expression; Gene Products, vif; Half-Life; HIV-1; Humans; Immunosorbent Techniques; Lactones; Leupeptins; Multienzyme Complexes; Mutation; Nucleoside Deaminases; Phosphorylation; Proteasome Endopeptidase Complex; Proteins; Recombinant Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Transfection; Ubiquitin; vif Gene Products, Human Immunodeficiency Virus | 2004 |
Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors.
Topics: Acetylcysteine; Animals; Biomarkers, Tumor; Blotting, Western; Cysteine; DNA-Binding Proteins; DNA, Complementary; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Genes, Dominant; Glutathione S-Transferase pi; Glutathione Transferase; Intracellular Signaling Peptides and Proteins; Isoenzymes; Kelch-Like ECH-Associated Protein 1; Lactones; Leupeptins; Luciferases; Mice; NF-E2-Related Factor 2; Oligonucleotides, Antisense; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Isoforms; Protein Structure, Tertiary; Proteins; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Time Factors; Trans-Activators; Transfection; Up-Regulation | 2005 |
Proteasome inhibitors eliminate protective effect of postconditioning in cultured neonatal cardiomyocytes.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Hypoxia; Cells, Cultured; Ischemic Preconditioning, Myocardial; Lactones; Leupeptins; Myocytes, Cardiac; Necrosis; Oxygen Consumption; Protease Inhibitors; Proteasome Inhibitors; Rats | 2006 |
Proteasome inhibitor differentially regulates expression of the major immediate early genes of human cytomegalovirus in human central nervous system-derived cell lines.
Topics: Activating Transcription Factor 2; Cell Line; Central Nervous System; Cytomegalovirus; Cytomegalovirus Infections; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Lactones; Leupeptins; Oligopeptides; Protease Inhibitors; Proteasome Inhibitors; Proto-Oncogene Proteins c-jun | 2009 |
Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma.
Topics: Animals; Cell Line, Tumor; Etoposide; G1 Phase; Gene Deletion; Genes, p16; Half-Life; Humans; Lactones; Leupeptins; Melanocytes; Melanoma; Mice; Mice, Transgenic; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Tumor Suppressor Protein p53; Ubiquitin | 2011 |
Pretreatment with proteasome inhibitors protects against oxidative injuries via PPARα-dependent and -independent pathways in ARPE-19 cells.
Topics: Aldehydes; Anilides; Cells, Cultured; Cysteine Proteinase Inhibitors; Electrophoretic Mobility Shift Assay; Humans; Lactones; Leupeptins; Oxazoles; Oxidative Stress; PPAR alpha; Retinal Pigment Epithelium; Tyrosine; Vitamin K 3 | 2012 |
Two inhibitors of the ubiquitin proteasome system enhance long-term memory formation upon olfactory conditioning in the honeybee (Apis mellifera).
Topics: Animals; Bees; Conditioning, Classical; Lactones; Leupeptins; Memory, Long-Term; Odorants; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Ubiquitin | 2014 |